Quantitative analysis for Belite Bio, Inc (BLTE) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Hold (52.0) (grade C). 28 signals analyzed (23 differentiated alt-data).
BLTE stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $158.50 | $154.22 | $154.50 |
| 2026-05-11 | $158.65 | $151.97 | $151.97 |
| 2026-05-21 | $148.14 | $139.00 | $144.25 |
| 2026-06-03 | $137.82 | $132.90 | $137.23 |
| 2026-06-15 | $144.82 | $139.20 | $144.24 |
| 2026-06-26 | $152.46 | $146.70 | $148.73 |
| 2026-07-09 | $155.88 | $150.40 | $153.24 |
| 2026-07-21 | $161.21 | $151.35 | $161.08 |
| 2026-07-31 | $161.00 | $155.18 | $158.61 |
| 2026-08-12 | $181.56 | $172.55 | $178.94 |
| 2026-08-24 | $161.75 | $157.77 | $158.87 |
| 2026-09-03 | $171.78 | $159.86 | $171.09 |
How Belite Bio, Inc stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| BLCO | Bausch + Lomb Corporation | $5.8B | — |
| CNTA | Centessa Pharmaceuticals plc | $6.2B | — |
| LEGN | Legend Biotech Corporation | $5.2B | — |
| STVN | Stevanato Group S.p.A. | $4.8B | — |
View all Health Care stocks by valuation and signals →
Belite Bio, Inc (BLTE) scores Hold (52.0), with no measured dimension below 42. Its highest are technicals at 62, ML forecast at 61, across 3 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 62 |
| ML forecast | 61 |
| analyst consensus | 42 |
StoQuant analyzes 28 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Belite Bio, Inc (BLTE): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/BLTE"><img src="https://stoquant.com/badge/BLTE.svg" alt="Belite Bio, Inc (BLTE) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.